Education
About Us
Working with TipRanks
Follow Us
Theravance Biopharma (TBPH)
NASDAQ:TBPH
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 64.38M | $ 57.42M | $ 51.35M | $ 55.31M | $ 71.86M |
| Gross Profit | $ 64.38M | $ 16.80M | $ 44.76M | $ 48.02M | $ -189.10M |
| Operating Income | $ -46.95M | $ -56.03M | $ -91.96M | $ -257.78M | $ -297.76M |
| EBITDA | $ -46.95M | $ -40.87M | $ -79.86M | $ -249.39M | $ -294.00M |
| Net Income | $ -56.42M | $ -55.19M | $ -92.82M | $ -199.43M | $ -278.02M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 88.35M | $ 102.43M | $ 327.48M | $ 173.47M | $ 292.94M |
| Total Assets | $ 354.16M | $ 382.00M | $ 607.40M | $ 374.82M | $ 469.06M |
| Total Debt | $ 49.82M | $ 49.16M | $ 74.12M | $ 652.08M | $ 647.06M |
| Net Debt | $ 12.02M | $ 9.61M | $ -224.05M | $ 562.12M | $ 565.59M |
| Total Liabilities | $ 178.62M | $ 169.00M | $ 165.60M | $ 713.39M | $ 772.81M |
| Stockholders' Equity | $ 175.54M | $ 213.00M | $ 441.80M | $ -338.57M | $ -303.75M |
| Cash Flow | |||||
| Free Cash Flow | $ -11.87M | $ -29.48M | $ -187.56M | $ -211.26M | $ -257.02M |
| Operating Cash Flow | $ -11.54M | $ -27.00M | $ -186.99M | $ -207.86M | $ -250.40M |
| Investing Cash Flow | $ 12.28M | $ -32.70M | $ 1.15B | $ 124.49M | $ 10.72M |
| Financing Cash Flow | $ -2.50M | $ -198.93M | $ -758.81M | $ 91.86M | $ 263.08M |